Snake venom serine proteinase (SVSP)

Snake venom serine proteinases are glycosylated enzymes found primarily in the venoms of Viperidae family snakes, with some presence in Elapidae and Colubridae families[1][2]. These enzymes belong to the chymotrypsin-like serine protease superfamily and are classified within the PA clan and S1 family[2]. They contain the highly conserved catalytic triad consisting of His57, Asp102, and Ser195[1][3]. SVSPs are among the best-characterized proteins in snake venom and evolved from a kallikrein-like serine protease that emerged with the Toxicofera clade, which includes snakes and certain lizards[2]. Despite showing high sequence similarity across species, particularly in their signal peptides and untranslated regions, the mature protein sequences show considerable diversity, allowing for varied substrate specificities[1]. These enzymes are multifunctional and act on various stages of the prey's hemostatic system[2]. The most commonly described activity is thrombin-like function, where they cleave fibrinogen to produce fibrin, though unlike true thrombin, they do not activate factor XIII and are not inhibited by heparin[3]. SVSPs can also function as kallikrein-like enzymes, platelet aggregators, and activators of plasminogen, factor X, factor V, prothrombin, and protein C[2]. Many enzymes can act on multiple substrates, producing either pro-coagulant or anti-coagulant effects[2]. Structurally, SVSPs contain 12 conserved cysteine residues forming disulfide bonds, N-terminal signal peptides (typically 18 amino acids), and activation peptides (typically 6 amino acids)[1]. They are predicted to be N-glycosylated, which increases their molecular mass beyond what would be predicted from amino acid sequence alone[1]. Interestingly, some SVSPs have mutations in their catalytic triad residues and are termed serine protease homologues. These variants may lack classical enzymatic activity but could have evolved alternative toxic functions[1]. The evolution of SVSP diversity appears to involve multiple mechanisms including accelerated evolution at the amino acid level, alternative splicing, and accelerated segment switching in specific surface regions[1]. SVSPs have significant biotechnological potential as diagnostic reagents, antithrombotic agents, and tools for understanding hemostasis mechanisms[3]. Their ability to affect multiple aspects of the coagulation cascade makes them valuable for both research and potential therapeutic applications[2].

Other names

Snake venom serine protease (SVSP)Viper venom serine protease (VVSP)Thrombin-like enzyme (TLE)Serine proteinase

Snake venom serine proteinases act through multiple mechanisms including thrombin-like activity (cleaving fibrinogen α and β chains to form fibrin), kallikrein-like activity, plasminogen activation, factor X activation, factor V activation, prothrombin activation, and protein C activation. They can exhibit both pro-coagulant and anti-coagulant effects depending on the specific substrate recognized.